Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate

Alan M. Nieder, Adrienne J K Carmack, Paul D. Sved, Sandy S. Kim, Murugesan Manoharan, Mark S. Soloway

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Objectives. To evaluate the risk of long-term biochemical recurrence for patients who receive cell-salvaged blood. Radical retropubic prostatectomy (RRP) is historically associated with the potential for significant blood loss. Different blood management strategies include blood donation, hemodilution, preoperative erythropoietin, and intraoperative cell salvage (IOCS). Oncologic surgeons have been reluctant to use IOCS because of the potential risk of tumor dissemination. Methods. We retrospectively analyzed an RRP database and compared those who did and did not receive cell-salvaged blood by baseline parameters, pathologic outcomes, and biochemical recurrence. We also stratified our patients according to the risk of recurrence. Results. A total of 1038 patients underwent RRP between 1992 and 2003. Of these, 265 (25.5%) received cell-salvaged blood and 773 (74.5%) did not. The two groups had similar baseline characteristics. No differences were found between the two groups when compared by risk of seminal vesicle invasion or positive surgical margins. Those who received cell-salvaged blood had a lower risk of extraprostatic extension. The median follow-up for all patients was 40.2 months. The overall risk of biochemical recurrence at 5 years for those who did and did not receive cell-salvaged blood was 15% and 18%, respectively (P = 0.76). No significant differences were found in the risk of biochemical recurrence when patients were stratified according to low, intermediate, and high risk. Conclusions. IOCS is a safe and effective blood management strategy for patients undergoing RRP. The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted.

Original languageEnglish
Pages (from-to)730-734
Number of pages5
JournalUrology
Volume65
Issue number4
DOIs
StatePublished - Apr 1 2005

Fingerprint

Prostatectomy
Recurrence
Blood Cells
Hemodilution
Seminal Vesicles
Erythropoietin
Blood Donors
Neoplasms
Databases

ASJC Scopus subject areas

  • Urology

Cite this

Nieder, A. M., Carmack, A. J. K., Sved, P. D., Kim, S. S., Manoharan, M., & Soloway, M. S. (2005). Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. Urology, 65(4), 730-734. https://doi.org/10.1016/j.urology.2004.10.062

Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. / Nieder, Alan M.; Carmack, Adrienne J K; Sved, Paul D.; Kim, Sandy S.; Manoharan, Murugesan; Soloway, Mark S.

In: Urology, Vol. 65, No. 4, 01.04.2005, p. 730-734.

Research output: Contribution to journalArticle

Nieder, AM, Carmack, AJK, Sved, PD, Kim, SS, Manoharan, M & Soloway, MS 2005, 'Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate', Urology, vol. 65, no. 4, pp. 730-734. https://doi.org/10.1016/j.urology.2004.10.062
Nieder, Alan M. ; Carmack, Adrienne J K ; Sved, Paul D. ; Kim, Sandy S. ; Manoharan, Murugesan ; Soloway, Mark S. / Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate. In: Urology. 2005 ; Vol. 65, No. 4. pp. 730-734.
@article{007b08b852624624820c8f83d245de09,
title = "Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate",
abstract = "Objectives. To evaluate the risk of long-term biochemical recurrence for patients who receive cell-salvaged blood. Radical retropubic prostatectomy (RRP) is historically associated with the potential for significant blood loss. Different blood management strategies include blood donation, hemodilution, preoperative erythropoietin, and intraoperative cell salvage (IOCS). Oncologic surgeons have been reluctant to use IOCS because of the potential risk of tumor dissemination. Methods. We retrospectively analyzed an RRP database and compared those who did and did not receive cell-salvaged blood by baseline parameters, pathologic outcomes, and biochemical recurrence. We also stratified our patients according to the risk of recurrence. Results. A total of 1038 patients underwent RRP between 1992 and 2003. Of these, 265 (25.5{\%}) received cell-salvaged blood and 773 (74.5{\%}) did not. The two groups had similar baseline characteristics. No differences were found between the two groups when compared by risk of seminal vesicle invasion or positive surgical margins. Those who received cell-salvaged blood had a lower risk of extraprostatic extension. The median follow-up for all patients was 40.2 months. The overall risk of biochemical recurrence at 5 years for those who did and did not receive cell-salvaged blood was 15{\%} and 18{\%}, respectively (P = 0.76). No significant differences were found in the risk of biochemical recurrence when patients were stratified according to low, intermediate, and high risk. Conclusions. IOCS is a safe and effective blood management strategy for patients undergoing RRP. The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted.",
author = "Nieder, {Alan M.} and Carmack, {Adrienne J K} and Sved, {Paul D.} and Kim, {Sandy S.} and Murugesan Manoharan and Soloway, {Mark S.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1016/j.urology.2004.10.062",
language = "English",
volume = "65",
pages = "730--734",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Intraoperative cell salvage during radical prostatectomy is not associated with greater biochemical recurrence rate

AU - Nieder, Alan M.

AU - Carmack, Adrienne J K

AU - Sved, Paul D.

AU - Kim, Sandy S.

AU - Manoharan, Murugesan

AU - Soloway, Mark S.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Objectives. To evaluate the risk of long-term biochemical recurrence for patients who receive cell-salvaged blood. Radical retropubic prostatectomy (RRP) is historically associated with the potential for significant blood loss. Different blood management strategies include blood donation, hemodilution, preoperative erythropoietin, and intraoperative cell salvage (IOCS). Oncologic surgeons have been reluctant to use IOCS because of the potential risk of tumor dissemination. Methods. We retrospectively analyzed an RRP database and compared those who did and did not receive cell-salvaged blood by baseline parameters, pathologic outcomes, and biochemical recurrence. We also stratified our patients according to the risk of recurrence. Results. A total of 1038 patients underwent RRP between 1992 and 2003. Of these, 265 (25.5%) received cell-salvaged blood and 773 (74.5%) did not. The two groups had similar baseline characteristics. No differences were found between the two groups when compared by risk of seminal vesicle invasion or positive surgical margins. Those who received cell-salvaged blood had a lower risk of extraprostatic extension. The median follow-up for all patients was 40.2 months. The overall risk of biochemical recurrence at 5 years for those who did and did not receive cell-salvaged blood was 15% and 18%, respectively (P = 0.76). No significant differences were found in the risk of biochemical recurrence when patients were stratified according to low, intermediate, and high risk. Conclusions. IOCS is a safe and effective blood management strategy for patients undergoing RRP. The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted.

AB - Objectives. To evaluate the risk of long-term biochemical recurrence for patients who receive cell-salvaged blood. Radical retropubic prostatectomy (RRP) is historically associated with the potential for significant blood loss. Different blood management strategies include blood donation, hemodilution, preoperative erythropoietin, and intraoperative cell salvage (IOCS). Oncologic surgeons have been reluctant to use IOCS because of the potential risk of tumor dissemination. Methods. We retrospectively analyzed an RRP database and compared those who did and did not receive cell-salvaged blood by baseline parameters, pathologic outcomes, and biochemical recurrence. We also stratified our patients according to the risk of recurrence. Results. A total of 1038 patients underwent RRP between 1992 and 2003. Of these, 265 (25.5%) received cell-salvaged blood and 773 (74.5%) did not. The two groups had similar baseline characteristics. No differences were found between the two groups when compared by risk of seminal vesicle invasion or positive surgical margins. Those who received cell-salvaged blood had a lower risk of extraprostatic extension. The median follow-up for all patients was 40.2 months. The overall risk of biochemical recurrence at 5 years for those who did and did not receive cell-salvaged blood was 15% and 18%, respectively (P = 0.76). No significant differences were found in the risk of biochemical recurrence when patients were stratified according to low, intermediate, and high risk. Conclusions. IOCS is a safe and effective blood management strategy for patients undergoing RRP. The risk of biochemical recurrence was not increased for those who received cell-salvaged blood. Concerns about spreading tumor cells by way of IOCS would seem unwarranted.

UR - http://www.scopus.com/inward/record.url?scp=17144420158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144420158&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2004.10.062

DO - 10.1016/j.urology.2004.10.062

M3 - Article

C2 - 15833517

AN - SCOPUS:17144420158

VL - 65

SP - 730

EP - 734

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -